Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/10/26 16:23 | 9/8/26 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO,In | 6 | M.dm | 1,967 | 16.39 | 0 | 120 | 195 | 182 | D | ||||||||||||||
9/10/26 16:23 | 9/8/26 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO,In | 6 | S.dm | -1,967 | 16.39 | 0 | -120 | 182 | D | |||||||||||||||
8/12/26 16:19 | 8/10/26 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 4 | M.d | 1,252 | 19.11 | 0 | 66 | 102 | 130 | D | ||||||||||||||
8/12/26 16:19 | 8/10/26 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 4 | S.d | -1,252 | 19.11 | 0 | -66 | 130 | D | |||||||||||||||
8/12/26 16:19 | 8/10/26 | BCAX | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 4 | M.d | 640 | 15.99 | 0 | 40 | 12 | 362 | D | ||||||||||||||
8/12/26 16:19 | 8/10/26 | BCAX | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 4 | S.d | -640 | 15.99 | 0 | -40 | 362 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |